Search results
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 4 days agoWhat happens next The committee voted that for most people with mild cognitive impairment or mild...
Jordan Bardella could soon be French PM at 28. But for many he remains an enigma
BBC via Yahoo News· 2 hours agoWith his TikTok habit, Mr Bardella obviously connects with the young. He regularly posts short...
California's Democratic leaders clash with businesses over curbing retail theft. Here's what to know
San Francisco Chronicle· 22 hours agoThe two most likely paths under consideration this year are a ballot initiative to create harsher...
The RI legislature has closed up shop. Here's what passed − and what failed
The Providence Journal via Yahoo News· 17 hours agoPassed: Legislation to allow the expungement of the record of one or more felony convictions for...
Is This Huge News for This Ultra-High-Dividend Income Stock?
Motley Fool via Yahoo Finance· 10 hours agoThe Motley Fool recommends British American Tobacco P.l.c. and recommends the following options:...
Economist Harry Dent predicts stock market crash worse than 2008 crisis: The ‘bubble of all bubbles’
FOX Business· 6 days agoSpeaking in an updated interview with Fox News Digital, Dent cautioned that the "everything" bubble...
How 80s cowpunk legends Jason And The Scorchers snatched defeat from the jaws of victory
Louder Sound via Yahoo News· 9 hours agoWithout them it’s doubtful whether the rebirth of southern rock would be possible. And life without...
Stock Market Forecast For The Next Six Months Is Stacking Up Well. But Don't Ignore These Risks.
Investor's Business Daily· 1 day agoAs the midpoint of 2024 nears, the stock market forecast is looking hopeful, building on the same...
What Should You Do If You Miss a Dose of Anti-Obesity Medication?
Verywell Health via Yahoo News· 1 day agoWith shortages continuing, many that have found success with new anti-obesity medications are having...
Sarepta Jumps After Rival Gene Therapy From Pfizer Flops
Investor's Business Daily· 2 days agoThe news gives Sarepta Therapeutics (SRPT) an edge heading to June 21, when the Food and Drug Administration will decide whether to fully approve Elevidys for patients with ...